Cervarix and the adjuvant conundrum
14 September 2009
Peter Charlish
Please Login to read the full article.
14 September 2009
Peter Charlish
News that an FDA advisory committee has recommended the approval of GlaxoSmithKline’s HPV vaccine Cervarix will be welcomed in many quarters.
For young women at risk of HPV infection and its sequelae, which can include cervical cancer, it will mean greater choice. Until now, the only...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Advanced Gardisil: Merck (with Qiagen) tests cervical cancer waters in Rwanda
- GAVI negotiates HPV vaccine prices for developing countries
- US Capitol Capsule: IOM focus on affordable 'essential' benefits expected to stir debate on drug prices
- Mirabegron approved in first market as Gardasil and Rotarix also get formal Japanese nod
FEATURES
Other Informa Features
EVENTS
09 February 2012
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
